These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

129 related articles for article (PubMed ID: 20146182)

  • 1. [Screening of adults with schizophrenia for metabolic complications caused by atypical antipsychotics].
    Cohen D
    Tijdschr Psychiatr; 2010; 52(2):111-5. PubMed ID: 20146182
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Clozapine screening: white bloodcell counts no longer sufficient].
    Cohen D;
    Tijdschr Psychiatr; 2010; 52(11):785-90. PubMed ID: 21064021
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Hyperglycemia and antipsychotic medications.
    Haupt DW; Newcomer JW
    J Clin Psychiatry; 2001; 62 Suppl 27():15-26; discussion 40-1. PubMed ID: 11806485
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Antipsychotic-induced weight gain and metabolic abnormalities: implications for increased mortality in patients with schizophrenia.
    Casey DE; Haupt DW; Newcomer JW; Henderson DC; Sernyak MJ; Davidson M; Lindenmayer JP; Manoukian SV; Banerji MA; Lebovitz HE; Hennekens CH
    J Clin Psychiatry; 2004; 65 Suppl 7():4-18; quiz 19-20. PubMed ID: 15151456
    [No Abstract]   [Full Text] [Related]  

  • 5. Beyond white blood cell monitoring: screening in the initial phase of clozapine therapy.
    Cohen D; Bogers JP; van Dijk D; Bakker B; Schulte PF
    J Clin Psychiatry; 2012 Oct; 73(10):1307-12. PubMed ID: 23140648
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Clozapine and diabetic ketoacidosis].
    Kristensen SH; Pørksen NK
    Ugeskr Laeger; 2003 Jan; 165(5):475-6. PubMed ID: 12599849
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Antipsychotic drugs and cardiovascular safety: current studies of prolonged QT interval and risk of ventricular arrhythmia].
    Gury C; Canceil O; Iaria P
    Encephale; 2000; 26(6):62-72. PubMed ID: 11217540
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Efficacy and tolerability of ziprasidone versus risperidone as augmentation in patients partially responsive to clozapine: a randomised controlled clinical trial.
    Zink M; Kuwilsky A; Krumm B; Dressing H
    J Psychopharmacol; 2009 May; 23(3):305-14. PubMed ID: 18562423
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Minimizing the risks associated with QTc prolongation in people with schizophrenia. A consensus statement by the Cardiac Safety in Schizophrenia Group].
    Ames D; Camm J; Cook P; Falkai P; Gury C; Hurley R; Johnson G; Piepho R; Vieweg V;
    Encephale; 2002; 28(6 Pt 1):552-62. PubMed ID: 12506268
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Ketoacidosis as a side-effect of clozapine: a case report.
    Kostakoğlu AE; Yazici KM; Erbaş T; Güvener N
    Acta Psychiatr Scand; 1996 Mar; 93(3):217-8. PubMed ID: 8739670
    [No Abstract]   [Full Text] [Related]  

  • 11. Clinical experience with insulin resistance, diabetic ketoacidosis, and type 2 diabetes mellitus in patients treated with atypical antipsychotic agents.
    Henderson DC
    J Clin Psychiatry; 2001; 62 Suppl 27():10-4; discussion 40-1. PubMed ID: 11806484
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Diabetic ketoacidosis with clozapine treatment.
    Maule S; Giannella R; Lanzio M; Villari V
    Diabetes Nutr Metab; 1999 Apr; 12(2):187-8. PubMed ID: 10554900
    [No Abstract]   [Full Text] [Related]  

  • 13. Differential effects of clozapine versus other antipsychotics on clinical outcome and dopamine release in the brain.
    Advokat C
    Essent Psychopharmacol; 2005; 6(2):73-90. PubMed ID: 15765792
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Atypical pharmacologic characteristics of an antipsychotic drug: clozapine].
    Gosselin O; Ribeyre JM; Kahn JP
    Encephale; 1997 Sep; 23 Spec No 4():2-6. PubMed ID: 9417400
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Ogilvie Syndrome induced by clozapine].
    de Bruin GJ; Bac DJ; van Puijenbroek EP; van der Klooster JM
    Ned Tijdschr Geneeskd; 2009; 153():B437. PubMed ID: 20051163
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Implications for anaesthesia in a patient established on clozapine treatment.
    Doherty J; Bell PF; King DJ
    Int J Obstet Anesth; 2006 Jan; 15(1):59-62. PubMed ID: 16256331
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Clozapine: the commitment to patient safety.
    Alphs LD; Anand R
    J Clin Psychiatry; 1999; 60 Suppl 12():39-42. PubMed ID: 10372610
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Clozapine maintenance therapy in schizophrenia.
    Gaszner P; Makkos Z
    Prog Neuropsychopharmacol Biol Psychiatry; 2004 May; 28(3):465-9. PubMed ID: 15093952
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Choosing between atypical antipsychotics: weighing the risks and benefits.
    Bailey KP
    Arch Psychiatr Nurs; 2002 Jun; 16(3 Suppl 1):S2-S11. PubMed ID: 12046019
    [No Abstract]   [Full Text] [Related]  

  • 20. [Clozapine in the treatment of under-age schizophrenia].
    Haapasalo-Pesu KM
    Duodecim; 2009; 125(15):1635-8. PubMed ID: 19769179
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.